News about our knowledge of the brain and behavior

Visit BrainBlog

Biotech: Link Medicine and Neurodegenerative Disorders

Posted on September 30, 2008

From a company press release:September 30, 2008 Media Contact: Greg Kelley, Feinstein Kean Healthcare(+++) +++-++++Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders Co-led by Clarus Ventures and SV Life Sciences,the Financing will Advance Preclinical and Clinical ProgramsCAMBRIDGE, Mass. - Link Medicine Corporation, a privately held biotechnology company advancing novel approaches for the treatment of neurodegenerative diseases, announced today that it has obtained $40 million of Series C equit...

Original article link


alzheimers , alzheimers disease , protein , proteins